Epidemiology of chronic hepatitis B in Majeedia Unani Hospital, New Delhi.

  • Shabnam Ansari Department of Biotechnology, Faculty of Natural Sciences, Jamia Millia Islamia, New Delhi, India.
  • Mohammad Akhtar Siddiqui MD, Department of Moalajat, School of Unani Medical Education and Research, Jamia Hamdard, New Delhi, India.
  • Sharad Malhotra DNB, Department of Gastroenterology, Batra Hospital and research center, New Delhi, India
  • Mohammad Maaz MD, Department of Moalajat, School of Unani Medical Education and Research, Jamia Hamdard, New Delhi, India.

Abstract

India has HBV carrier rate of 3.0% approximately with a high prevalence rate in the villages and remote areas. The variation in social, ethnic, economic, habits and other health conditions in different areas may explain the difference in outcomes of the disease. High-risk groups (especially tribals) also harbor significant disease burden and have a high prevalence of occult infection, supporting the potential of unknowingly spreading the disease. Hence identifying and targeting those population for public healthcare measure is the necessity to control the disease and promoting hepatitis B vaccination around the country. The present study was carried to out to elucidate epidemiology of chronic hepatitis B in the patients of Majeedia Unani Hospital New Delhi to locate high risk groups and areas for health education regarding lifestyle, preventive measures, early disease detection and proper adherence to drugs and of health care workers on adoption of proper precautions while carrying out their duties, and aggressive vaccination strategies thereafter.

Downloads

Download data is not yet available.

Author Biographies

Mohammad Akhtar Siddiqui, MD, Department of Moalajat, School of Unani Medical Education and Research, Jamia Hamdard, New Delhi, India.

MD, Department of Moalajat, School of Unani Medical Education and Research, Jamia Hamdard, New Delhi, India.

Sharad Malhotra, DNB, Department of Gastroenterology, Batra Hospital and research center, New Delhi, India

DNB, Department of Gastroenterology, Batra Hospital and research center, New Delhi, India

Mohammad Maaz, MD, Department of Moalajat, School of Unani Medical Education and Research, Jamia Hamdard, New Delhi, India.

MD, Department of Moalajat, School of Unani Medical Education and Research, Jamia Hamdard, New Delhi, India.

References

1. World health organisation (WHO). Hepatitis B. [Internet]. 2018 [Cited 2018 August 30]. Available from: http://www.who.int/news-room/fact-sheets/detail/hepatitis-b.
2. Puri P. Tackling the Hepatitis B Disease Burden in India. J Clin Exp Hepatol. 2014; 4(4):312-9.
3. Siddiqui MA, Ansari S, Khan QA. Socio-demographic profile of health camp on viral hepatitis B and C at Maswasi, Rampur. Middle East journal of rehabilitation of health. 2017; 2:e44359.
4. Schalm SW, Janssen HLA. Treatment of HBeAg-Positive Chronic Hepatitis B with Conventional or Pegylated Interferon [Internet]. 2004 [Cited 2014 Feb 10]. P. 246, 251, 254. Available from:
http://www.aphc.info/wp-content/uploads/2014/10/07PHC_Book_Chapter18.pdf.
5. Warner N, Stephen L. Replication of Hepatitis B Virus. In: Boyer TD, Manns MP, Sanyal AJ. Zakim and Boyers Hepatology. 6th ed. Cananda: Elsevier; 2012. P. 86-94.
6. Lok ASF, McMahon BJ, Brown RS, Wong JB, Ahmed TA, Farah W. Antiviral therapy for chronic hepatitis B viral infections in adults: a systematic review and metanalysis. Hepatology. 2016; 63(1):1-13.
7. Anna SF, LokHari SC, Negro F. Hepatitis B & D. In: Schiff ER, Sorrell MF, Maddrey WC. Schiff's Disease of the Liver. 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. Vol. 1. P. 745-48, 752-53-4-5, 755-759, 760-2, 763, 764, 770-79.
8. Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH. AASLD Guidelines for Treatment of Chronic Hepatitis B. American Association for the Study of Liver Diseases Practice Guidelines [Internet]. 2015 [Cited 2016 June 10]. P. 1-23. Available from:
https://www.aasld.org/sites/default/files/guideline_documents/hep28156.pdf.
9. Kumar M, Sarin SK. Viral hepatitis eradication in India by 2080 -gaps, challenges & targets. Indian J Med Res. 2014; 140:1-4.
10. Tabri ABR. Al-Moalejaat Buqratiya. New Delhi: Central Council for Research In Unani Medicine; 1997. Vol 3. P. 197-217.
11. Ibne Sina (Avicenna). Al-Qanoon Fit-Tibb [Kantoori GH, Trans]. New Delhi: Aijaz Publishing; 2010. Vol 3, part 1. P. 854-854-859-862, 869-78.
12. Jurjani AH. Zakheera khwarzim shahi, [Khan HH, Trans]. Lucknow: Munshi Nawal Kishore publishing. Vol 2. Part 7. P. 368-382.
13. Khan H, Ikseere Azam [H. Kabiruddin, Trans]. New Delhi: Aijaz Publishing; 2010. P. 489, 505-515.
14. Razi AB. Kitabul-Hawi [Urdu translation]. New Delhi: Central council for research in Unani Medicine; 2000. Vol 7. P. 47-50, 52-73, 119-145.
15. Lok ASF, McMahon BJ. Correction to AASLD Practice Guideline: Chronic Hepatitis B [Internet]. 2007 [Cited 2014 March 20]. Available from:
file:///D:/HBV/Corrections%20to%20Guidelines%20on%20Chronic%20Hep%20B%20aasld.pdf
16. Kumar M, Sarin SK. Viral hepatitis eradication in India by 2080 -gaps, challenges & targets. Indian J Med Res. 2014;140:1-4.
17. Warner N, Stephen L. Replication of Hepatitis B Virus. In: Boyer TD, Manns MP, Sanyal AJ. Zakim and Boyers Hepatology. 6th ed. Cananda: Elsevier; 2012. P. 86-94.
Statistics
126 Views | 134 Downloads
How to Cite
Ansari, S., Siddiqui, M. A., Malhotra, S., & Maaz, M. (2019). Epidemiology of chronic hepatitis B in Majeedia Unani Hospital, New Delhi. Journal of Drug Delivery and Therapeutics, 9(2), 237-243. https://doi.org/10.22270/jddt.v9i2.2571